Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -42.69 | N/A |
PEG Ratio (TTM) | 0.23 | N/A |
P/S Ratio (TTM) | 1.98 | N/A |
P/B Ratio (TTM) | 5.07 | N/A |
P/FCF Ratio (TTM) | 16.49 | N/A |
Price to 5YR AVG Earnings Ratio | -10.03 | N/A |
Price to 5YR AVG FCF Ratio | -93.84 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.51% | N/A |
ROE (TTM) | -12.14% | N/A |
Net Profit Margin (TTM) | -4.64% | N/A |
ROIC 5YR AVG | -103.17% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -20.69% | -2.77% | 23.02% |
Revenue | 3.33% | 19.90% | 12.64% |
Net Income | -21.89% | -12.94% | 17.30% |
Cash Flow | 610.00% | 377.15% | 254.34% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.86 | N/A |
Quick Ratio (TTM) | 0.86 | N/A |
D/E Ratio (TTM) | 0.62 | N/A |
Interest Coverage (TTM) | -25.53 | N/A |
Piotroski F-Score | 7 | N/A |
Altman Z-Score | 0.05 | N/A |
LTL to 5YR AVG FCF | -10.40 | N/A |
Shares Outstanding Growth 5YR AVG | 4.90% | N/A |